Study Links Weight Loss Drugs to Reduced Suicide Risk in Obese Teens

Research shows adolescents on GLP-1 medications have fewer suicidal thoughts compared to those on lifestyle interventions.

Israeli researchers found a 33% lower risk of suicidal thoughts in teens using GLP-1 drugs like Wegovy and Ozempic.
The study analyzed medical records of nearly 7,000 obese adolescents aged 12 to 18 over a period of up to three years.
GLP-1 drugs, initially for diabetes, are gaining popularity for weight loss due to their appetite-reducing effects.
While teens on these drugs experienced more gastrointestinal side effects, they had a lower risk of acute pancreatitis.
Researchers urge further studies to confirm findings and explore the long-term mental health effects of these medications.